Skip to main content
logo
Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,080.00
-50.00 (-0.97%)
At close: Sep 11, 2026

Kyung Dong Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
17,8318,5295,470-20,70812,16112,672
Depreciation & Amortization
3,9773,6785,4205,8496,7047,011
Loss (Gain) From Sale of Assets
-2,726-2,094-92.39-61.03142.27-73.22
Asset Writedown & Restructuring Costs
223.47-197.41---
Loss (Gain) From Sale of Investments
-4,955748.83-1,765-2,1491,709-786.97
Loss (Gain) on Equity Investments
-1,63266.38-503.27-3,083-11,387155.57
Provision & Write-off of Bad Debts
55.18--1,57764.766
Other Operating Activities
4,2902,476-6,917-236.454,218-2,090
Change in Accounts Receivable
-2,6102,250-2,8164,146-3,855-3,561
Change in Inventory
4,036172.68-7,837-4,494-2,619-636.73
Change in Accounts Payable
178.61-344.59123.61-776.13-92.641,873
Change in Other Net Operating Assets
1,9961,452646.219,904-8,119-2,207
Operating Cash Flow
20,66516,934-8,074-31.94-1,07512,422
Operating Cash Flow Growth
12.94%-----27.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-16,059-18,394-7,618-6,290-10,574-3,926
Sale of Property, Plant & Equipment
2,6142,518993.5344.32126.36222.18
Sale (Purchase) of Intangibles
-449.94-1,968-3,792-1,677161.82-811.28
Investment in Securities
12,32312,64710,51322,985-3,74912,145
Other Investing Activities
3,3323,7552,1683,3011,4492,786
Investing Cash Flow
1,972-1,1432,26418,664-12,58510,713

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-151,609162,522110,59468,182-
Long-Term Debt Issued
-18,400----
Total Debt Issued
95,941170,009162,522110,59468,182-
Short-Term Debt Repaid
--160,250-138,897-119,663-44,251-481.93
Long-Term Debt Repaid
--79.52-148.88-573.83-1,595-1,534
Total Debt Repaid
-114,018-160,330-139,046-120,237-45,846-2,016
Net Debt Issued (Repaid)
-18,0789,68023,476-9,64322,336-2,016
Repurchase of Common Stock
---1,280--750.51-5,517
Dividends Paid
-8,320-8,083-10,854-10,854-10,894-13,834
Other Financing Activities
-1,092-1,399-1,729-921.28-304.11-106.26
Financing Cash Flow
-27,490198.629,613-21,41810,388-21,474

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
148.849.97186.5811.7517.78153.47
Miscellaneous Cash Flow Adjustments
-0-0--0-
Net Cash Flow
-4,70416,0403,990-2,774-3,2541,815

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
4,606-1,460-15,692-6,322-11,6498,496
Free Cash Flow Growth
-55.00%-----
Free Cash Flow Margin
2.29%-0.74%-8.09%-3.89%-6.38%4.78%
Free Cash Flow Per Share
167.14-53.82-582.38-232.98-428.12308.70
Levered Free Cash Flow
747.78-8,976-22,117510.19-2,7736,388
Unlevered Free Cash Flow
1,821-7,867-20,7671,508-2,2316,429

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,0921,3991,769921.28244.116.26
Cash Income Tax Paid
1,559387.84,7772,7965,6928,698
Change in Working Capital
3,6003,530-9,88318,780-14,686-4,532